CO - China Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD

China Cord Blood Corporation

Bank of China Tower
48th Floor
Central
Hong Kong

http://www.chinacordbloodcorp.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees1,059

Key Executives

NameTitlePayExercisedAge
Ms. Ting ZhengChief Exec. Officer, Director & Interim CEO of Beijing DivisionN/AN/A45
Mr. Albert Chen CFACFO, Chief Accounting Officer & DirectorN/AN/A41
Ms. Xin XuChief Technology OfficerN/AN/A63
Ms. Rui ArashiyamaChief Exec. Officer of Guangdong Division & Zhejiang DivisionN/AN/A58
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

China Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2017, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company is based in Central, Hong Kong.

Corporate Governance

China Cord Blood Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.